# Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

> **NCT01999270** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 6 (actual)

## Conditions studied

- Astrocytoma, Oligoastrocytoma, Mixed
- Ganglioneuroma
- Glioma
- Ganglioglioma
- Glioblastoma Multiforme Glioma

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** Bevacizumab
- **DEVICE:** FDOPA-PET/MRI imaging

## Key facts

- **NCT ID:** NCT01999270
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999270, "Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01999270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*